
Conjunctival Dehiscence and Scleral Necrosis following Iodine-125 Plaque Brachytherapy for Uveal Melanoma: A Report of 3 Cases
Author(s) -
D. H. Berry,
Dilraj S. Grewal,
Prithvi Mruthyunjaya
Publication year - 2018
Publication title -
ocular oncology and pathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.444
H-Index - 10
eISSN - 2296-4681
pISSN - 2296-4657
DOI - 10.1159/000481858
Subject(s) - medicine , brachytherapy , dehiscence , melanoma , necrosis , iodine , uvea , surgery , ophthalmology , pathology , radiation therapy , cancer research , materials science , metallurgy
Plaque brachytherapy is currently the most common treatment for uveal melanoma and has many known potential complications. Here we present 3 cases of early conjunctival and scleral necrosis following iodine-125 plaque.